FDA Approved: GRISOFULVIN — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s original application for griseofulvin, a generic antifungal, enabling its marketing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatophytosis
• Onychomycosis

Drugs mentioned

• Griseofulvin (GRISEOFULVIN)

Snippet

ORIG AP for GRISOFULVIN (GRISOFULVIN)